Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease
Authors:
- David A van HeelDHDavid A van Heel
- Subrata GhoshSGSubrata Ghosh
- Matt ButlerMBMatt Butler
- Karen A HuntKHKaren A Hunt
- Anna MC LundbergALAnna MC Lundberg
- Tariq AhmadTATariq Ahmad
- Dermot PB McGovernDMDermot PB McGovern
- Clive OnnieCOClive Onnie
- Kenichi NegoroKNKenichi Negoro
- Sue GoldthorpeSGSue Goldthorpe
- Brian Mj FoxwellBFBrian Mj Foxwell
- Christopher G MathewCMChristopher G Mathew
- 1 May 2005
- journal article
- Published by Elsevier in The Lancet
- Vol. 365 (9473) , 1794-1796
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The role of Toll-like receptors and Nod proteins in bacterial infectionMolecular Immunology, 2004
- NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responsesNature Immunology, 2004
- Structural Requirements of Synthetic Muropeptides to Synergize with Lipopolysaccharide in Cytokine InductionJournal of Biological Chemistry, 2004
- Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) DetectionJournal of Biological Chemistry, 2003
- Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2Journal of Biological Chemistry, 2003
- CARD15/NOD2 Mutational Analysis and Genotype-Phenotype Correlation in 612 Patients with Inflammatory Bowel DiseaseThe American Journal of Human Genetics, 2002
- Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseNature, 2001
- A frameshift mutation in NOD2 associated with susceptibility to Crohn's diseaseNature, 2001